9158 — CUC Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapContrarian

Annual income statement for CUC, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	Yuho	Yuho	Yuho	Tanshin
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	35,314	35,210	33,025	47,043	54,353
Cost of Revenue
Gross Profit	14,246	13,776	15,923	23,172	25,413
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	31,635	31,527	29,288	41,700	48,570
Operating Profit	3,679	3,683	3,737	5,343	5,783
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,622	3,634	4,138	5,246	5,110
Provision for Income Taxes
Net Income After Taxes	2,220	2,404	2,607	3,077	2,743
Minority Interest
Net Income Before Extraordinary Items
Net Income	2,707	2,423	2,595	3,131	2,854
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,707	2,423	2,595	3,131	2,854
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	134	87.2	94	103	97.4
Dividends per Share